Insight Molecular Diagnostics, Inc. (IMDX)
4.76
-0.34
(-6.67%)
USD |
NASDAQ |
Dec 17, 16:00
Insight Molecular Diagnostics Research and Development Expense (Annual): 8.796M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| FONAR Corp. | 1.576M |
| XWELL, Inc. | -- |
| ProPhase Labs, Inc. | 0.594M |
| Veracyte, Inc. | 68.02M |
| Exagen, Inc. | 5.375M |